Dosing regimens before and following long-term treatment with recombinant factor VIII Fc fusion protein (rFVIIIFc) in adults and adolescents with severe hemophilia A

被引：0
|
作者：
Konkle, Barbara A. [1 ]
Pasi, K. John [2 ]
Perry, David J. [3 ]
Mahlangu, Johnny [4 ]
Rangarajan, Savita [5 ]
Hanabusa, Hideji [6 ]
Pabinger, Ingrid [7 ]
Lethagen, Stefan [8 ,9 ]
Cristiano, Lynda M. [10 ]
Yuan, Huixing [10 ]
Pierce, Glenn F. [10 ]
Allen, Geoffrey [10 ]
机构：
[1] Bloodworks Northwest, Seattle, WA USA
[2] Barts & London Comprehens Care Ctr, London, England
[3] Addenbrookes Hosp, Cambridge, England
[4] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa
[5] Hampshire Hosp NHS Trust, Basingstoke, Hants, England
[6] Ogikubo Hosp, Tokyo, Japan
[7] Med Univ Wien, Vienna, Austria
[8] Sobi, Stockholm, Sweden
[9] Univ Copenhagen, Copenhagen, Denmark
[10] Biogen, Cambridge, MA USA
来源：
HAEMOPHILIA | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [21] Population pharmacokinetic analysis of long-lasting recombinant factor VIII Fc fusion protein (rFVIIIFc) in patients with severe haemophilia A
    Neelakantan, S.
    Li, S.
    Powell, J.
    Josephson, N.
    Pasi, J.
    Perry, D.
    Shapiro, A. D.
    Ragni, M.
    Kulkarni, R.
    Fogarty, P.
    Brennan, A.
    Pierce, G.
    Jiang, H.
    Nestorov, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 354 - 355
  • [22] Cost-Effectiveness Analysis of Recombinant Factor VIII Fc-Fusion Protein (rFVIIIFc) for the Treatment of Severe Hemophilia A in Italy Incorporating Real-World Dosing and Joint Health Data
    Bullement, Ash
    McMordie, Samuel Thomas
    Hatswell, Anthony James
    Li, Nanxin
    Wilson, Koo
    PHARMACOECONOMICS-OPEN, 2020, 4 (01) : 133 - 142
  • [23] Long-term efficacy and safety of prophylactic treatment with recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with severe haemophilia A: Final longitudinal analysis of A-LONG/kids A-LONG and ASPIRE
    Konkle, B.
    Young, G.
    Liesner, R.
    Mahlangu, J.
    Brown, S. A.
    Nolan, B.
    Tripkovic, N.
    Feng, J.
    Barnowski, C.
    HAEMOPHILIA, 2019, 25 : 55 - 55
  • [24] Cost-Effectiveness Analysis of Recombinant Factor VIII Fc-Fusion Protein (rFVIIIFc) for the Treatment of Severe Hemophilia A in Italy Incorporating Real-World Dosing and Joint Health Data
    Ash Bullement
    Samuel Thomas McMordie
    Anthony James Hatswell
    Nanxin Li
    Koo Wilson
    PharmacoEconomics - Open, 2020, 4 : 133 - 142
  • [25] Dosing intervals and bleeding rates before and following treatment with recombinant factor VIII Fc fusion protein in patients with severe haemophilia A: experience from the A-LONG clinical study
    Oldenburg, J.
    Shapiro, A.
    Ragni, M. V.
    Kulkarni, R.
    Kulke, S.
    Potts, J.
    Neelakantan, S.
    Nestorov, I.
    Dumont, J. A.
    Jiang, H.
    Brennan, A.
    Pierce, G. F.
    HAEMOPHILIA, 2014, 20 : 60 - 61
  • [26] Analysis of bleeding rates in pediatric subjects with target joints and severe hemophilia A receiving prophylaxis with recombinant factor viii fc fusion protein (RFVIIIFC) in kids a-long
    Nolan, B.
    Young, G.
    Rangarajan, S.
    Wang, M.
    Kerlin, B. A.
    Leung, A.
    Tsao, E.
    Glazebrook, D., V
    Pierce, G. F.
    Allen, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 347 - 348
  • [27] Analysis of clinical target joint bleeding on prophylactic regimens with recombinant Factor VIII Fc fusion protein in patients with severe hemophilia A
    Kulkarni, Roshni
    Ragni, Margaret V.
    Baker, Ross I.
    Pasi, John
    Manco-Johnson, Marilyn J.
    Potts, James
    Brennan, Aoife
    Pierce, Glenn F.
    HAEMOPHILIA, 2014, 20 : 94 - 94
  • [28] Evaluation of the toxicology and pharmacokinetics of recombinant factor VIII Fc (rFVIIIFc) fusion protein in animals
    Dumont, Jennifer A.
    Loveday, Ken
    Light, David R.
    Pierce, Glenn F.
    Jiang, Haiyan
    HAEMOPHILIA, 2014, 20 : 21 - 21
  • [29] Safety, Efficacy, and Pharmacokinetics of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously-Treated Children with Severe Hemophilia a (Kids-ALONG)
    Young, Guy
    Mahlangu, Johnny N.
    Kulkarni, Roshni
    Nolan, Beatrice
    Liesner, Raina
    Pasi, John
    Barnes, Christopher
    Neelakantan, Srividya
    Gambino, Giulia
    Cristiano, Lynda M.
    Barnowski, Christopher
    Pierce, Glenn F.
    Allen, Geoffrey A.
    BLOOD, 2014, 124 (21)
  • [30] Clinical Development of Rfviiifc, a Novel, Long-Lasting Recombinant Fc Fusion Replacement Factor, in Patients with Severe Hemophilia A
    Powell, Jerry
    Josephson, Neil
    Perry, David
    Nugent, Karen
    Gor, Dee
    Pestana, Harold
    Franc-Poole, Elke
    Li, Lian
    Greblikas, Feriandas
    Allen, Geoff
    Dabora, Sandra
    Krassova, Snejana
    Luk, Alvin
    Pierce, Glenn
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 : S176 - S177
12345